Wellorithm review

You cannot answer the only question that matters here before you pay. Wellorithm publishes no price for semaglutide, tirzepatide, its branded pens or sermorelin — every button leads to a two-minute quiz, and the FAQ handles the cost question by describing what weight-loss programs generally charge rather than what this one does. For a reader planning a quarter dose, that is the whole calculation withheld. Which is a shame, because the product is genuinely well suited to you. Both drugs come as an oral dissolving tablet as well as an injection, and a tablet is a far more forgiving way to take a small dose than measuring a part-filled syringe — few providers offer that on both molecules. Two claims on the homepage also don't survive a look at the rest of the site: it says "Serving All 50 States" while its own FAQ says 49 and leaves out Louisiana, and the four people captioned as board-certified obesity specialists are listed elsewhere under Cardiac Surgery, Pediatric Clinic, Gynecology and Cardiac Surgery.

Vs median

Not comparable — no figure is published before intake

Market

$59–$1,300/mo is the full published spread on this site

Structure

No low-dose price published

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Varies by dose, plan or tier

Start with Wellorithm↗

Wellorithm does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

A telehealth weight-management platform with an unusually wide catalog for this category — compounded semaglutide and tirzepatide each available as a weekly injection OR an oral dissolving tablet, four branded pens, and sermorelin. For a low-dose reader the ODT route is the draw: a tablet is a far more forgiving vehicle for a small dose than a syringe. What you cannot do is cost it. No price appears anywhere on the public site, the pricing page is broken, and every product link routes into a two-minute quiz. Two claims on its own homepage also fail against the rest of the site.

See how Wellorithm works↗

No price anywhere on the public site — the pricing page is broken and every product CTA leads to an intake quiz, so the one thing a microdoser needs to know (what a fraction of a dose costs) cannot be established before signing up

• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
• The site contradicts itself on coverage: the homepage says “Serving All 50 States” while its own FAQ says 49 states and excludes Louisiana
• The four clinicians presented as “board-certified obesity specialists” are captioned Cardiac Surgery, Pediatric Clinic, Gynecology and Cardiac Surgery — none in obesity medicine
• “100% Customer Satisfaction” is stated as a headline fact and is not substantiable

Wellorithm is one of 407 low-dose GLP-1 programs compared on this site, and 261 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• Sublingual troches and drops
• Oral semaglutide (Rybelsus)
• Is compounded GLP-1 safe?
• Microdose & reconstitution calculator
• Pen click calculator